1. Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives
- Author
-
Dekang Ren, Shizheng Xiong, Yujie Ren, Xueni Yang, Xinmiao Zhao, Jiaming Jin, Miaomiao Xu, Tingming Liang, Li Guo, and Lixing Weng
- Subjects
Adjuvants ,Therapeutic cancer vaccines ,In situ vaccination ,Immunogenic cell death ,Biotechnology ,TP248.13-248.65 - Abstract
Preventive cancer vaccines are highly effective in preventing viral infection-induced cancer, but advances in therapeutic cancer vaccines with a focus on eliminating cancer cells through immunotherapy are limited. To develop therapeutic cancer vaccines, the integration of optimal adjuvants is a potential strategy to enhance or complement existing therapeutic approaches. However, conventional adjuvants do not satisfy the criteria of clinical trials for therapeutic cancer vaccines. To improve the effects of adjuvants in therapeutic cancer vaccines, effective vaccination strategies must be formulated and novel adjuvants must be identified. This review offers an overview of the current advancements in therapeutic cancer vaccines and highlights in situ vaccination approaches that can be synergistically combined with other immunotherapies by harnessing the adjuvant effects. Additionally, the refinement of adjuvant systems using cutting-edge technologies and the elucidation of molecular mechanisms underlying immunogenic cell death to facilitate the development of innovative adjuvants have been discussed.
- Published
- 2024
- Full Text
- View/download PDF